鳖甲煎丸和艾迪注射液联合肝动脉化疗栓塞治疗中晚期肝癌的疗效观察

目的 探讨鳖甲煎丸和艾迪注射液联合肝动脉化疗栓塞治疗中晚期肝癌的临床疗效.方法 选取中晚期肝癌患者164例,采用随机数字表法分为观察组和对照组,观察组90例,对照组74例.对照组用常规肝动脉化疗栓塞法进行治疗,观察组在对照组治疗基础上联合应用鳖甲煎丸和艾迪注射液进行治疗.结果 与对照组比较,治疗后观察组患者的外周血白细胞(WBC)显著升高(P＜0.05).治疗后观察组患者平均白蛋白(ALB)水平显著高于对照组,观察组治疗有效率和生活质量改善情况明显优于对照组(P＜0.01).结论 鳖甲煎丸和艾迪注射液与肝动脉化疗栓塞联合应用治疗中晚期肝癌可明显改善患者肝功能,显著提高患者生活质量,提高治疗有效率,值得在临床上推广使用.

Effect of Biejiajian pills and Aidi injection combined transcatheter arterial chemoembolization for moderate or advanced liver cancer

Objective To evaluate the clinical value of Biejiajian pills and Aidi injection combined transcatheter arterial chemoembolization for moderate or advanced liver cancer.Methods 164 cases of patients with moderate or advanced liver cancer were divided into observation group (90) and control group (74) at random.The control group was treated with conventional method of transcatheter arterial chemoembolization,and the observation group was treated with Biejiajian pills and Aidi injection combined transcatheter arterial chemoembolization.Results Compared with the control group,the observation group of patients after treatment significantly increased the WBC of peripheral blood (P ＜ 0.05),with statistical significance.After treatment,the average level of ALB of the observation group were significantly higher than that of control group,the efficient observation of treatment group and the patient's quality of life improved were significantly higher than the control group(P ＜ 0.01),with statistical significance.Conclusions Biejiajian pills and Aidi injection combined transcatheter arterial chemoembolization can obviously improve liver function,improve patient's quality of life and the treatment efficiency,which is worth popularizing in clinical use.